BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38487485)

  • 1. Cost-Utility Analysis of Screening for Diabetic Retinopathy in China.
    Zhang Y; Bai W; Li R; Du Y; Sun R; Li T; Kang H; Yang Z; Tang J; Wang N; Liu H
    Health Data Sci; 2022; 2022():9832185. PubMed ID: 38487485
    [No Abstract]   [Full Text] [Related]  

  • 2. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis.
    Liu H; Li R; Zhang Y; Zhang K; Yusufu M; Liu Y; Mou D; Chen X; Tian J; Li H; Fan S; Tang J; Wang N
    Lancet Glob Health; 2023 Mar; 11(3):e456-e465. PubMed ID: 36702141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
    Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H
    JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness and cost-utility of traditional and telemedicine combined population-based age-related macular degeneration and diabetic retinopathy screening in rural and urban China.
    Li R; Yang Z; Zhang Y; Bai W; Du Y; Sun R; Tang J; Wang N; Liu H
    Lancet Reg Health West Pac; 2022 Jun; 23():100435. PubMed ID: 35355615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
    Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
    Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Health economic evaluation of telemedicine diabetic retinopathy examination using a non-mydriatic fundus camera in China].
    Fan JX; Zhang M; Zhao WY; Han Y; Hu WT; Jia HX; Sun XD
    Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):919-929. PubMed ID: 37936360
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
    Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J
    PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
    Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
    Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model.
    Tang J; Liang Y; O'Neill C; Kee F; Jiang J; Congdon N
    Lancet Glob Health; 2019 Jul; 7(7):e968-e978. PubMed ID: 31122906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study.
    Kawasaki R; Akune Y; Hiratsuka Y; Fukuhara S; Yamada M
    Ophthalmic Epidemiol; 2015 Feb; 22(1):4-12. PubMed ID: 25517603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China.
    Li R; Zhang K; Lu Z; Mou D; Wang J; Li H; Fan S; Wang N; Liu H
    BMJ Open; 2023 Sep; 13(9):e073219. PubMed ID: 37673456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
    Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
    BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists.
    van Katwyk S; Jin YP; Trope GE; Buys Y; Masucci L; Wedge R; Flanagan J; Brent MH; El-Defrawy S; Tu HA; Thavorn K
    Value Health; 2017 Sep; 20(8):1034-1040. PubMed ID: 28964434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up.
    Romero-Aroca P; de la Riva-Fernandez S; Valls-Mateu A; Sagarra-Alamo R; Moreno-Ribas A; Soler N; Puig D
    BMC Ophthalmol; 2016 Aug; 16():136. PubMed ID: 27491545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of diabetic retinopathy screening programs using telemedicine: a systematic review.
    Avidor D; Loewenstein A; Waisbourd M; Nutman A
    Cost Eff Resour Alloc; 2020; 18():16. PubMed ID: 32280309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing a digital comprehensive myopia prevention and control strategy for children and adolescents in China: a cost-effectiveness analysis.
    Li R; Zhang K; Li SM; Zhang Y; Tian J; Lu Z; Li H; Wang L; Wan X; Zhang F; Li L; Jin ZB; Wang N; Liu H
    Lancet Reg Health West Pac; 2023 Sep; 38():100837. PubMed ID: 37520278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Satisfaction of patients and primary care professionals with a teleophthalmology-based screening programme for diabetic retinopathy in a rural area in Castilla y León, Spain.
    Valpuesta Martin Y; Pacheco Callirgos GE; Maroto Martín TM; Piriz Veloso M; Hernández Santamaría S; López Gálvez MI
    Rural Remote Health; 2020 Jan; 20(1):5180. PubMed ID: 31941342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of Osimertinib vs Docetaxel-bevacizumab in Third-line Treatment in EGFR T790M Resistance Mutation Advanced Non-Small Cell Lung Cancer in China.
    Rui M; Li H
    Clin Ther; 2020 Nov; 42(11):2159-2170.e6. PubMed ID: 33028495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression.
    Pyne JM; Fortney JC; Tripathi SP; Maciejewski ML; Edlund MJ; Williams DK
    Arch Gen Psychiatry; 2010 Aug; 67(8):812-21. PubMed ID: 20679589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Utility Analysis of Wide-Field Imaging as an Auxiliary Technology for Retinopathy of Prematurity Care in Brazil.
    Neves LM; Haefeli LM; Zin AA; Steffen RE; Vasconcelos ZFM; Pinto M
    Front Pediatr; 2021; 9():757258. PubMed ID: 34976892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.